SC
KZR

Slow Capital’s Kezar Life Sciences KZR Stock Holding History

Slow Capital’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,066
Closed -$1.3M – 140
2022
Q3 		$1.3M Buy
+15,066
New +$1.46M 0.28% 105
2022
Q2 		– Sell
-15,066
Closed -$2.5M – 140
2022
Q1 		$2.5M Buy
+15,066
New +$2.16M 0.47% 70
2019
Q2 		– Sell
-20,554
Closed -$3.65M – 171
2019
Q1 		$3.65M Buy
20,554
+19,640
+2,149% +$3.87M 1.45% 8
2018
Q4 		$216K Buy
+914
New +$223K 0.1% 141

Other funds holding KZR

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Slow Capital's KZR Position: Q4 2022 in Review

Slow Capital sold out of Kezar Life Sciences (KZR) in Q4 2022, closing a stake of 15,066 shares — an estimated $1.3M sold.

Slow Capital first reported a position in KZR in Q4 2018 and held it in 4 quarters. The position peaked at $3.65M in Q1 2019. 123 funds tracked by Wall St. Rank hold KZR as of Q4 2022.

  • Slow Capital reported no remaining Kezar Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Slow Capital sold 15,066 Kezar Life Sciences shares in Q4 2022, an estimated $1.3M.
  • Slow Capital first reported a position in Kezar Life Sciences in Q4 2018 and held it in 4 quarters.
  • Slow Capital's Kezar Life Sciences position peaked at $3.65M in Q1 2019.
  • 123 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2022.

Based on Slow Capital's 13F filing for Q4 2022, filed 13 Feb 2023.